-
Expertise
- Class certification
- Damages estimation
- Fraud analysis
- Mergers and acquisitions
- Monopolization
- Pharmaceutical economics
- Reimbursement and claims data
-
Industries
- Biotechnology
- Health insurance
- Hospitals
- Medical devices
- Medicare and Medicaid
- PBMs and GPOs
- Pharmaceuticals
- Physicians
Spotlight
-
Alabama Supreme Court ruling validates Eric Gaier's testimony regarding pharmaceutical pricing
The Alabama Supreme Court recently overturned three jury verdicts totaling nearly $275 million against pharmaceutical manufacturers AstraZeneca, GlaxoSmithKline, and Novartis Pharmaceuticals Corporation. The ruling cites many arguments presented by Dr. Eric Gaier, who provided deposition testimony on behalf of all three defendants and testified at trial on behalf of AstraZeneca.
Read more
Practices
Healthcare
Bates White’s Healthcare Practice comprises economists, academics, and experts who possess a deep understanding of the healthcare industry and how it is shaped by the evolving landscape of government regulation and antitrust jurisprudence.
Our professionals have played pivotal roles in healthcare litigation involving reimbursement and pricing issues in cases alleging fraud, breach of contract, and violation of state and federal statutes. We also have extensive experience providing economic analysis and expert testimony for clients in antitrust investigations including mergers and conduct investigations. Our defensible and rigorous approach is built on sound economic theory, extensive empirical work, and facility with critical legal issues.
As a result of our extensive healthcare litigation and consulting experience, we understand the issues that face all types of healthcare participants, including:
- Public and private medical insurance payors
- Physicians, hospitals, surgery centers, pharmacies, and other providers
- Pharmaceutical, biological, and medical device manufacturers
- The Centers for Medicare and Medicaid Services (CMS), Food and Drug Administration (FDA), Veteran’s Administration (VA), and other government entities
- Pharmacy benefit managers, group purchasing organizations, and other healthcare intermediaries
-
Expertise
- Class certification
- Damages estimation
- Fraud analysis
- Mergers and acquisitions
- Monopolization
- Pharmaceutical economics
- Reimbursement and claims data
-
Industries
- Biotechnology
- Health insurance
- Hospitals
- Medical devices
- Medicare and Medicaid
- PBMs and GPOs
- Pharmaceuticals
- Physicians